Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
China flag China · Delayed Price · Currency is CNY
8.60
+0.03 (0.35%)
Feb 3, 2026, 1:25 PM CST

SHA:600867 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
2,7081,9762,9302,7423,2192,855
Other Revenue
33.1533.15145.8136.4749.2237.13
2,7412,0103,0752,7783,2682,892
Revenue Growth (YoY)
12.74%-34.66%10.69%-14.98%12.99%4.14%
Cost of Revenue
790.58547.46621.05628.13586.99582.86
Gross Profit
1,9511,4622,4542,1502,6812,309
Selling, General & Admin
1,3541,2521,0471,1141,2551,091
Research & Development
140.6599.3104.96146.71166.86106.93
Other Operating Expenses
25.3313.1311.6514.5711.27-34.35
Operating Expenses
1,5131,3491,1841,2681,4351,165
Operating Income
437.6113.021,270882.291,2461,145
Interest Expense
-21.81-14.38-5.17-0.28--10.17
Interest & Investment Income
1,211130.82103.61942.66304.3243.64
Currency Exchange Gain (Loss)
0.70.70.4700.24-0.45
Other Non Operating Income (Expenses)
251.31-1.14-1.65-0.880.33-7.38
EBT Excluding Unusual Items
1,878229.021,3681,8241,5501,170
Gain (Loss) on Sale of Investments
-0.40.520.96-0.370.37
Gain (Loss) on Sale of Assets
-255.35-239.83-3.13-0.11-13.48-62.44
Asset Writedown
-106.24-80.68-7-1.74-11.53-
Legal Settlements
-60.82-60.82----
Other Unusual Items
-44.038.167.916.629.35-
Pretax Income
1,412-143.751,3661,8301,5341,108
Income Tax Expense
201.78-99.63197.97247.69225.86177.81
Earnings From Continuing Operations
1,210-44.121,1681,5821,309930.32
Minority Interest in Earnings
15.691.4-0.090.06-0.34-0.41
Net Income
1,226-42.721,1681,5821,308929.92
Net Income to Common
1,226-42.721,1681,5821,308929.92
Net Income Growth
259.17%--26.17%20.92%40.69%14.63%
Shares Outstanding (Basic)
1,9552,1361,9792,0022,0442,022
Shares Outstanding (Diluted)
1,9552,1361,9792,0022,0442,022
Shares Change (YoY)
-8.58%7.92%-1.15%-2.04%1.12%-0.32%
EPS (Basic)
0.63-0.020.590.790.640.46
EPS (Diluted)
0.63-0.020.590.790.640.46
EPS Growth
292.86%--25.32%23.44%39.13%15.00%
Free Cash Flow
213.89-108.99513.4370.21579.62712.69
Free Cash Flow Per Share
0.11-0.050.260.180.280.35
Dividend Per Share
0.2500.2500.2500.5000.3000.210
Dividend Growth
---50.00%66.67%42.86%5.00%
Gross Margin
71.16%72.76%79.81%77.39%82.04%79.85%
Operating Margin
15.96%5.62%41.31%31.75%38.12%39.57%
Profit Margin
44.72%-2.13%37.97%56.93%40.03%32.15%
Free Cash Flow Margin
7.80%-5.42%16.69%13.32%17.74%24.64%
EBITDA
625.44300.021,4561,0331,3891,299
EBITDA Margin
22.81%14.93%47.35%37.20%42.51%44.92%
D&A For EBITDA
187.84187185.87151.17143.65154.54
EBIT
437.6113.021,270882.291,2461,145
EBIT Margin
15.96%5.62%41.31%31.75%38.12%39.57%
Effective Tax Rate
14.29%-14.49%13.54%14.72%16.05%
Revenue as Reported
2,7412,0103,0752,7783,268-
Advertising Expenses
-93.2463.5946.79143.61120.46
Source: S&P Global Market Intelligence. Standard template. Financial Sources.